Forum Topics PME PME ASX Announcements

Pinned straw:

Added a month ago

Another great win from the PME team.

PME signs 7-year, A$90M contract with Beth Israel Lahey Health 18th May 2026 HIGHLIGHTS  PME signs 7-year, A$90M contract with Beth Israel Lahey Health.  Contract is for Full Stack, including Visage 7 Viewer, Visage 7 Workflow and Visage 7 Open Archive.  Visage 7 platform to be implemented in the cloud.  Transaction-based model with potential upside. 

All of the old favourites: Full Stack and transaction based with upside potential. Congratulations to Sam and the team.


Disclosure: Have sold out IRL but looking to buy back in.


mikebrisy
Added a month ago

@BullsWool what I also like about this deal is that it appears to be a new customer, transitioning off "legacy PACS".

For the thesis to hold, this is exactly what we want to see. Network customers (14 hospitals) leaping right to the latest generation full stack solutions, implemented across the network and committed for 7 years ... with $PME the choice. A$90m/7years is not their largest by any means, but it is still a chunky deal, so very good to see, particularly given that this customer is best considered a large, regional IDN, and not one of the national mega-networks. It is however an important customers, in that it includes both Academic Medical Centres ($PME's high-end "home") through to community and specialty hospitals, indicating $PME'swide appeal.

All that said, I am still itching to see $PME sign the next "Trinity". The mega-networks are there for the taking!

The second announcement today was not so great - resignation of Clayton Hatch. Clayton had only recently transitioned from the role of long-serving CFO into a combined Business Operations and Investor Relations role (an odd pairing, unless you consider it part of a CEO-succession development plan. Which I did!) It sounds like an amicable parting, as on the face of it he is serving with 3 months. The fact that the two announcements came out on the same day indicates to me that the Board and Clayton agreed to hold off announcing his resignation until the next chunky deal was signed. In my mind that further indicates that both sides are still on good terms with each other.

But what was that all about? Clayton hadn't been out of the CFO role long. Was his new role a manufactured one so that Sam could delay announcing his departure? It will be interesting to see where Clayton ends up.

Back to $PME, it does open up the succession management question again.

Disc: Held

22

BoredSaint
Added a month ago

As @ArrowTrades pointed out yesterday, Clayton Hatch has become CFO of Artrya (AYA.asx).

daee72242291f121f140f4cea43a69c19e7728.png

Disc: Hold PME, no position in AYA

12